Asia Pacific Anatomic Pathology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and Service (Instruments, Consumables, and Services), Application (Disease Diagnosis, Drug Discovery and Development, and Others), and End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others)

Code: TIPRE00026303 | Pages: 149 | Industry: Biotechnology | Date: Dec 2021
Covid

Market Introduction

The anatomic pathology is a significant part of the study and treatment of the diseases. Anatomic pathology is a broad field that includes decedent pathology, surgical pathology, cytopathology, neuropathology, and ophthalmic pathology. The anatomic pathology is usually performed in the medical laboratories of hospitals and diagnostics laboratories.

 


Get more information on this report :



Market Overview and Dynamics

The Asia Pacific anatomic pathology market is expected to reach US$ 5,697.76 million by 2028 from US$ 3,556.33 million in 2021; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. The growth of the market is attributed to a few key driving factors such as the rising number of clinical trials for anticancer drugs and growing development of new technologies and launch of products in anatomic pathology. However, the lack of skilled professionals and the implementation of stringent government regulations hinder the market growth.

The number of cancer diagnosis procedures performed worldwide is increasing with the rise in prevalence of the disease. Despite significant progress in cancer prevention, diagnosis, and treatment, there is a large unmet medical need for the treatments for major cancer types, such as lung, prostate, breast, etc. Clinical trials play an important role in medical advancements and the development of evidence-based healthcare. These trials have the potential to improve the standard of care for all individuals who are diagnosed with cancer. Many researchers are conducting clinical trials to test new treatments for both common and rare cancer types. The FDA has approved a total of 47 immunotherapies as of December 2019 that includes almost every major cancer type. These drugs are now the standard of care for many cancers. Clinical trials find better ways to prevent, diagnose, and treat cancer. As the result of medications approval after going through clinical trials, many cancer patients live longer with improved quality of life. Pathology plays an important role in every phase of clinical trials. Thus, the rising number of clinical trials for anticancer drugs is likely to support the growth of the anatomic pathology market in the coming years. There is huge scope for the integration of machine learning (ML) and artificial intelligence (AI)-based systems in medical streams, including anatomic pathology. Several anatomic pathology laboratories are becoming increasingly aware of the benefits of digitization and AI in practice. Moreover, recent technological advancements and regulatory approvals are encouraging the digitalization of laboratories operations to improve the speed and accuracy of processes. The properly designed AI-based tools hold great potential for improving the workflow efficiency and diagnostic accuracy in pathology. The AI technology has potential in advancing pathology imaging, which can allow greater precision in diagnosis, leading to more specific treatment.  Digital pathology, a growing subfield within anatomical pathology, uses digital technologies to streamline data collection and management. Additionally, the digital pathology can reduce sample-to-result turnaround time and streamline the central pathology review process, further offering opportunities to increase trial efficiency. Various players operating in the market are focused on bringing innovative solutions for patients. Further, RadNet, an imaging services provider, and Hologic, a diagnostic products developer, collaborated on the development of AI tools for breast health. Thus, the introduction of new technologies and products is likely to emerge as a significant trend in the anatomic pathology market during the forecast period.

Countries in Asia Pacific are witnessing a massive challenges due to the growing cases of COVID-19. Considering the economic operations and geographic conditions, the outbreak of the disease has adversely affected medical tourism and diagnostic kits and drugs manufacturing, supply chains, and distribution. It caused other problems due to the shortage of healthcare infrastructure in low-income countries in the region. To prevent the spread of the novel coronavirus, restrictive measures have been taken in countries such as India, South Korea, Singapore, Malaysia, and the Philippines. The measures have disrupted all industries, such as cancer diagnostics. According to a recent article published by National Institute of Health, in April 2020, cancer patients admitted at hospitals in Delhi, India, are facing immense hardships as their treatments and diagnosis and progress checking tests have been postponed as hospitals are busy dealing with COVID-19 cases. Moreover, in India, the outbreak embarked upon the already vulnerable laboratories with challenges related to the availability of workforce, transportation, deficiency of personal protective equipment and gadgets, delay in procurement of essential items, a decline in financial turnover, and apprehensions among the staff. Some laboratory sections worked round the clock during lockdown to provide diagnostic facilities to routine and COVID-19 cases. Also, histopathology and cytology workload reduced substantially, which hampered the Asia Pacific anatomic pathology market growth.

 

Key Market Segments

Based on product and service, the Asia Pacific anatomic pathology market is segmented into instruments, consumables, and services. The services segment held the largest share of the market in 2021, whereas the instruments segment is anticipated to register the highest CAGR of the market during the forecast period.

By application, the Asia Pacific anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest market share in 2021. However, the drug discovery and development segment is anticipated to register the highest CAGR of the market during 2021–2028.

The Asia Pacific anatomic pathology market, based on end user, is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The others segment consists of pharmaceutical and biotechnology companies and contract research organizations (CROs). The hospitals segment held the largest share of the market in 2021, and the diagnostic laboratories segment is anticipated to register the highest CAGR of the market during the forecast period.

 

Major Sources and Companies Listed

A few of the primary and secondary sources  referred to while preparing the report on the Asia Pacific anatomic pathology market are the Indian Society of Nephrology (ISN), Korean Diabetes Association (KDA), Japan Association for Diabetes Education and Care (JADEC). and National Center for Biotechnology Information (NCBI).

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of Asia Pacific anatomic pathology market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the Asia Pacific anatomic pathology market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific anatomic pathology market.

ASIA PACIFIC ANATOMIC PATHOLOGY MARKET SEGMENTATION

By Products and Services

  • Services
  • Consumables
  • Instruments

By Application

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

By End User

  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

By Country

  • India
  • Japan
  • South Korea
  • Australia
  • China
  • Rest of Asia Pacific

Company Profiles

  • F. HOFFMANN-LA ROCHE LTD.
  • Danaher
  • Hologic, Inc.
  • Agilent Technologies, Inc.
  • BioGenex
  • Diapath S.p.A.
  • Bio SB
  • MERCK KGaA
  • BD
  • PHC Holdings Corporation

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Anatomic Pathology Market – By Product and Services

1.3.2        Asia Pacific Anatomic Pathology Market – By Application

1.3.3        Asia Pacific Anatomic Pathology Market – By End User

1.3.4        Asia Pacific Anatomic Pathology Market – By Country

2.           Anatomic Pathology Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Anatomic Pathology Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific – PEST Analysis

4.3         Expert Opinions

5.           Anatomic Pathology Market — Key Market Dynamics

5.1         Key Market Drivers

5.1.1              Increase in Prevalence of Cancer and Other Diseases

5.1.2              Growing Focus on Personalized Medicines

5.2         Key Market Restraints

5.2.1              Lack of Skilled Professionals

5.2.2              Stringency of Government Regulations

5.3         Key Market Opportunities

5.3.1              Rise in Number of Clinical Trials for Anticancer Drugs

5.4         Future Trends

5.4.1              Development of New Technologies and Launch of Products

5.5         Impact Analysis

6.           Anatomic Pathology Market – Asia Pacific Analysis

6.1         Asia Pacific Anatomic Pathology Market Revenue Forecast and Analysis

7.           Anatomic Pathology Market Analysis – By Product and Service

7.1         Overview

7.2         Anatomic Pathology Market, by Product and Service (2020 and 2028)

7.3         Instruments

7.3.1        Overview

7.3.2        Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Consumables

7.4.1        Overview

7.4.2        Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Services

7.5.1        Overview

7.5.2        Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

8.           Anatomic Pathology Market Analysis – By Application

8.1         Overview

8.2         Anatomic Pathology Market, by Application (2020 and 2028)

8.3         Disease Diagnosis

8.3.1        Overview

8.3.2        Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Drug Discovery and Development

8.4.1        Overview

8.4.2        Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

9.           Anatomic Pathology Market Analysis – By End User

9.1         Overview

9.2         Anatomic Pathology Market, by End User (2020 and 2028)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Research Laboratories

9.4.1        Overview

9.4.2        Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Laboratories

9.5.1        Overview

9.5.2        Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

10.        Anatomic Pathology Market –Asia Pacific Analysis

10.1      Asia Pacific: Anatomic Pathology Market

10.1.1     Overview

10.1.2     Asia Pacific: Anatomic Pathology Market, by Country, 2021 & 2028 (%)

10.1.2.1       China: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       China: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.3     China Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

10.1.4     China Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.5     China Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.5.1       Japan: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1.1       Japan: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.6     Japan Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

10.1.7     Japan Anatomic Pathology Market, by Services – Revenue and Forecast to 2028 (USD Million)

10.1.8     Japan Anatomic Pathology Market, by Instruments – Revenue and Forecast to 2028 (USD Million)

10.1.9     Japan Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.10  Japan Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.10.1    India: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.10.1.1    India: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.11  India Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

10.1.12  India Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.13  India Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.13.1    South Korea: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.13.1.1    South Korea: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.14  South Korea Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

10.1.15  South Korea Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.16  South Korea Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.16.1    Australia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.16.1.1    Australia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.17  Australia Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

10.1.18  Australia Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.19  Australia Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.19.1    Rest of Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.19.1.1    Rest of Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

10.1.20  Rest of Asia Pacific Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

10.1.21  Rest of Asia Pacific Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.22  Rest of Asia Pacific Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact of COVID-19 Pandemic on Asia Pacific Anatomic Pathology Market

11.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.        Anatomic Pathology Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      F. HOFFMANN-LA ROCHE LTD.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Danaher

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Hologic, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Agilent Technologies, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      BioGenex

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Diapath S.p.A.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Bio SB

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      MERCK KGaA

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      BD

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   PHC Holdings Corporation

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             China Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 2.             China Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4.             Japan Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 5.             Japan Anatomic Pathology Market, by Services – Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan Anatomic Pathology Market, by Instruments – Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             India Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 10.          India Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 11.          India Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Korea Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Korea Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 14.          South Korea Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of Asia Pacific Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of Asia Pacific Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of Asia Pacific Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.          Organic Developments Done by Companies

Table 22.          Inorganic Developments Done by Companies

Table 23.          Glossary of Terms, Anatomic Pathology Market

 


LIST OF FIGURES

Figure 1.           Anatomic Pathology Market Segmentation

Figure 2.           Anatomic Pathology Market Segmentation, By Country

Figure 3.           Anatomic Pathology Market Overview

Figure 4.           Services Segment Held Largest Share of Anatomic Pathology Market

Figure 5.           Asia Pacific Anatomic Pathology Market – Leading Country Markets (US$ Million)

Figure 6.           Asia Pacific PEST Analysis

Figure 7.           Asia Pacific Anatomic Pathology Market Impact Analysis of Drivers and Restraints

Figure 8.           Asia Pacific Anatomic Pathology Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Anatomic Pathology Market Revenue Share, by Product and Service (2020 and 2028)

Figure 10.        Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Anatomic Pathology Market Revenue Share, by Application (2020 and 2028)

Figure 14.        Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Anatomic Pathology Market Revenue Share, by End User (2020 and 2028)

Figure 18.        Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Asia Pacific: Anatomic Pathology Market, by Key Country – Revenue (2021) (USD Million)

Figure 23.        Asia Pacific: Anatomic Pathology Market, by Country, 2021 & 2028 (%)

Figure 24.        China: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        Japan: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        India: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        South Korea: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Australia: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Rest of Asia Pacific: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. F. HOFFMANN-LA ROCHE LTD.
  2. Danaher
  3. Hologic, Inc.
  4. Agilent Technologies, Inc.
  5. BioGenex
  6. Diapath S.p.A.
  7. Bio SB
  8. MERCK KGaA
  9. BD
  10. PHC Holdings Corporation
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific anatomic pathology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific anatomic pathology market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Related Tags Asia Pacific Anatomic Pathology Market Asia Pacific Anatomic Pathology Market Research Asia Pacific Anatomic Pathology Market Insight Asia Pacific Anatomic Pathology Market Trends Asia Pacific Anatomic Pathology Market Forecast Asia Pacific Anatomic Pathology Market Share Asia Pacific Anatomic Pathology Market 2028 Asia Pacific Anatomic Pathology Market Growth Asia Pacific Anatomic Pathology Industry Sector Asia Pacific Anatomic Pathology PDF Report Asia Pacific Anatomic Pathology Analysis Asia Pacific Anatomic Pathology Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000